Fundz
Back to SEC Filings
10-KHIGH RiskDETERIORATING

Translational Development Acquisition Corp.

translational-development.com
Filed: May 11, 2026 CIK: 0001926599Energy
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-K filing content

Translational Development Acquisition Corp. has disclosed material control deficiencies with ineffective disclosure controls and procedures as of December 31, 2025. The filing appears incomplete, cutting off mid-sentence in the internal controls section, which raises additional transparency concerns for this SPAC entity.

Red Flags Detected (4)

Management concluded disclosure controls and procedures were NOT EFFECTIVE as of December 31, 2025

Filing appears incomplete - cuts off mid-sentence in critical internal controls section

Only controls and procedures section provided in 2096 words with no other business context

1 more red flag detected

Key Takeaways

SPAC has acknowledged material control deficiencies in disclosure procedures

Internal control assessment appears incomplete based on truncated filing

2 more takeaways

Filing Overview

Form TypeAnnual Report (10-K)
Filing DateMay 11, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence85%
Red Flags4

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Annual Report: Comprehensive filing covering the full fiscal year with audited financial statements.

View Full Filing on SEC.govBrowse More Filings